热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Alexa Fluor® 700 anti-mouse I-A/I-E Antibody
产品名称：
Alexa Fluor® 700 anti-mouse I-A/I-E Antibody
产品类别：
抗体
产品编号：
107621
产品应用：
107621
[价格]
规格 价格 库存
25µg ￥ 1128 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Activated C57BL/6 mouse spleen cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor? 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

SB - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor? 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor? 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

The M5/114.15.2 antibody reacts with a polymorphic determinant shared by the I-Ab, I-Ad, I-Aq, I-Ed, and I-Ek MHC class II alloantigens from mice carrying H-2p,r,q,b,d,u haplotypes. Clone M5/114.15.2 however does not react wtih I-Af, I-Ak, or I-As MHC class II alloantigens.1

Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemistry of frozen sections2,3,6, in vitro and in vivo blocking of antigen presentation or ligand binding4-7, and spatial biology (IBEX)17,18. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. Nos. 107655 & 107656).

Additional Product Notes

Iterative Bleaching Extended multi-pleXity (IBEX) is a fluorescent imaging technique capable of highly-multiplexed spatial analysis. The method relies on cyclical bleaching of panels of fluorescent antibodies in order to image and analyze many markers over multiple cycles of staining, imaging, and, bleaching. It is a community-developed open-access method developed by the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).

Application References

(PubMed link indicates BioLegend citation)
  1. Bhattacharya A, et al. 1981. J. Immunol. 127:2488. (IP)
  2. Viville S, et al. 1993. Cell 72:635. (IHC)
  3. Nelson AJ, et al. 1993. J. Immunol. 151:2453. (IHC)
  4. Shi Y, et al. 1998. J. Exp. Med. 187:367. (Block)
  5. Yamashita I, et al. 1993. Int. Immunol. 5:1139.
  6. Guo M, et al. 1995. Zygote 3:65. (IHC)
  7. Kim A, et al. 2004. Exp. Mol. Med. 36:428. (Block)
  8. Luckashenak NA, et al. 2006. J. Immunol. 177:5177.
  9. Venanzi ES, et al. 2007. J. Immunol. 179:5693.
  10. Christensen SR, et al. 2006. Immunity 25:417. PubMed
  11. Matte-Martone C, et al. 2008. Blood 111:3884. PubMed
  12. De Pascalis R, et al. 2008. Infect. Immun. 76:4311. PubMed
  13. Kuns RD, et al. 2009. Blood 113:5999. PubMed
  14. Sabatino JJ, et al. 2011. J. Exp. Med. 208:81. PubMed
  15. Draber P, et al. 2011. Mol Cell Biol. 22:4550. PubMed
  16. Fu H, et al. 2014. Nat Commun. 5:3436. PubMed
  17. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  18. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Huang W, et al. 2015. J Allergy Clin Immunol. . PubMed
  2. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  3. Mathur R, et al. 2019. Mucosal Immunol. 12:612. PubMed
  4. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  5. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  6. Kwong Chung CK, et al. 2017. Immunology. 150:221. PubMed
  7. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  8. Zhang R, et al. 2019. Cell Rep. 28:2647. PubMed
  9. Mancini M, et al. 2019. J Immunol. 202:1479. PubMed
  10. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  11. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  12. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  13. Dong L, et al. 2021. Cancer Cell. . PubMed
  14. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  15. Pack AD, et al. 2021. Cell Reports. 36(8):109586. PubMed
  16. Hearnden R, et al. 2021. STAR Protocols. 2(2):100422. PubMed
  17. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  18. Chikina AS, et al. 2020. Cell. 183:411. PubMed
  19. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  20. Tyagi AM et al. 2018. Immunity. 49(6):1116-1131 . PubMed
  21. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  22. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  23. Dupont C, et al. 2015. J Immunol. 195: 4369 - 4377. PubMed
  24. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  25. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  26. Chan YH, et al. 2019. EMBO Mol Med. 11:e10092. PubMed
  27. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  28. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  29. Uher O, et al. 2021. Cancers (Basel). 13:. PubMed
  30. Wiesner D, et al. 2015. PLoS Pathog. 11:1004701. PubMed
  31. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  32. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  33. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  34. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  35. Ruhland MK, et al. 2020. Cancer Cell. 37(6):786-799.e5. PubMed
  36. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  37. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  38. Ortiz-Bonilla CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  39. Sutherland TE, et al. 2021. Frontiers in Immunology. 12:715209. PubMed
  40. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  41. Brandi P, et al. 2022. Cell Rep. 38:110184. PubMed
  42. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  43. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  44. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  45. Dupont C, et al. 2014. PLoS Pathog. 10:1004047. PubMed
  46. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  47. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  48. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  49. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  50. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  51. De Simone G, et al. 2021. Immunity. :. PubMed
  52. Rhys HI, et al. 2018. EBioMedicine. 29:60. PubMed
  53. Macdougall CE et al. 2018. Cell metabolism. 27(3):588-601 . PubMed
  54. Martínez‐López M et al. 2019. Immunity. 50(2):446-461 . PubMed
  55. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  56. Chen YG, et al. 2020. Molecular Cell. 76(1):96-109. PubMed
  57. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  58. Blriot C, et al. 2021. Immunity. :. PubMed
  59. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  60. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  61. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  62. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  63. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  64. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  65. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  66. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  67. Kim DK, et al. 2022. Nat Commun. 13:6292. PubMed
  68. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  69. Desai P, et al. 2021. Cell. 184(5):1214-1231.e16. PubMed
  70. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  71. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  72. Quiding-J?rbrink M, et al. 2010. PLoS One. 5:e15018. PubMed
  73. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  74. Cunha LD et al. 2018. Cell. 175(2):429-441 . PubMed
  75. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  76. Winkler ES, et al. 2020. Cell. 182(4):901-918.e18. PubMed
  77. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  78. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  79. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  80. Utz SG, et al. 2020. Cell. 181(3):557-573. PubMed
  81. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  82. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  83. Meunier I, et al. 2015. PLoS One. 10: 0138055. PubMed
  84. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  85. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  86. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  87. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  88. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  89. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  90. Ceglia V, et al. 2021. J Immunol. 207:2060. PubMed
  91. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  92. Ubags ND, et al. 2021. J Allergy Clin Immunol. 1049:147. PubMed
  93. Droho S, et al. 2020. J Vis Exp. . PubMed
  94. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  95. Mogilenko DA et al. 2019. Cell. 177(5):1201-1216 . PubMed
  96. Braza MS et al. 2018. Immunity. 49(5):819-828 . PubMed
  97. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  98. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  99. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  100. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  101. Lee S, et al. 2021. Autophagy. Online ahead of print. PubMed
  102. C Khouili S, et al. 2020. Cell Rep. 33:108468. PubMed
  103. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  104. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
RRID
AB_493726 (BioLegend Cat. No. 107621) AB_493727 (BioLegend Cat. No. 107622)

Antigen Details

Structure
MHC class II
Distribution

B cell and activated T cells, APCs of the H-2b,d,q,r bearing mice

Function
Antigen presentation
Ligand/Receptor
CD3/TCR, CD4
Cell Type
Antigen-presenting cells, B cells, Dendritic cells, T cells, Tregs
Biology Area
Immunology, Innate Immunity
Molecular Family
MHC Antigens
Antigen References

1. Watts C. 1997. Ann. Rev. Immunol. 15:821.
2. Pamer E, et al. 1998. Ann. Rev. Immunol. 16:323.

Gene ID
14961 View all products for this Gene ID 14969 View all products for this Gene ID
UniProt
View information about I-A/I-E on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线